A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence.
|Eligibility criteria|| |
To be considered for the study you must meet the following criteria:
|Study details|| |
This is a randomised study and your participation in this study would be approximately 5 years.
Patients randomized to Arm A will receive standard radiation therapy and adjuvant endocrine therapy (standard of care).
Patients randomized to Arm B will not receive radiation therapy (omission of radiation therapy) and receive adjuvant endocrine therapy only.
You will be required to attend clinic visit approximately every 6 months and be required to complete Quality of life questionnaires throughout the study.
Sign up to this clinical trial here.
Newcastle NSW, Wesley Medical Centre QLD, Frankston VIC, Ringwood VIC